Categories
Cancer Complementary and alternative medicine Medicine Quackery

Let's make Dr. Stanislaw Burzynski do something good for cancer patients for a change

Today’s post will be relatively brief (for an Orac post, that is). The reason is that it’s some very sad news that depresses me greatly. It’s also because I don’t want to distract too much from the announcement I’d like to highlight. About a month and a half ago, around the same time that Stanislaw […]

Categories
Complementary and alternative medicine Homeopathy Medicine Quackery

Homeopaths swing and miss yet again…

Homeopathy amuses me. Homeopaths amuse me as well, which is why I’m resurrecting this post. It was originally published elsewhere a few years ago and somehow never crossposted here. So if it seems a bit dated, fear not; Orac hasn’t fired up his Tarial cells and managed to go back in time. Now, I realize […]

Categories
Cancer Complementary and alternative medicine Medicine Quackery

Stanislaw Burzynski: “Personalized gene-targeted cancer therapy” for dummies

Note: Orac is away somewhere warm recharging his Tarial cells for further science and skepticism. In the meantime, he is rerunning some of his favorite posts. Given that the blog seems to have been infiltrated with Burzynski trolls again and Eric Merola threatens to make a sequel to the execrable movie he made about Burzynski […]

Categories
Biology Cancer Clinical trials Medicine

NIH funding: The dreaded issue of conformity rears its ugly head again

For all the worship of “translational” research that is currently in vogue, it needs to be remembered that a robust pipeline of basic science progress upon which to base translational research and clinical trials is absolutely essential if progress in medicine is to continue. Without it, progress in SBM will slow and even grind to […]

Categories
Medicine Politics

Big pharma wins a battle on off-label prescribing

There’s a phenomenon known as off-label prescribing. Basically, to prescribe something off-label is to prescribe it for an indication that is not FDA-approved but that is supported by considerable evidence. For example, it could involve using an FDA-approved drug for an indication that is not within its approval, for an unapproved age range (such as […]